-+ 0.00%
-+ 0.00%
-+ 0.00%

Vera Therapeutics Q1 EPS $(0.81) Misses $(0.73) Estimate

Benzinga·05/06/2025 12:11:28
Listen to the news
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.73) by 10.96 percent. This is a 44.64 percent decrease over losses of $(0.56) per share from the same period last year.